BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 21974811)

  • 21. H3N2 influenza viruses in humans: Viral mechanisms, evolution, and evaluation.
    Allen JD; Ross TM
    Hum Vaccin Immunother; 2018; 14(8):1840-1847. PubMed ID: 29641358
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selection of antigenically advanced variants of seasonal influenza viruses.
    Li C; Hatta M; Burke DF; Ping J; Zhang Y; Ozawa M; Taft AS; Das SC; Hanson AP; Song J; Imai M; Wilker PR; Watanabe T; Watanabe S; Ito M; Iwatsuki-Horimoto K; Russell CA; James SL; Skepner E; Maher EA; Neumann G; Klimov AI; Kelso A; McCauley J; Wang D; Shu Y; Odagiri T; Tashiro M; Xu X; Wentworth DE; Katz JM; Cox NJ; Smith DJ; Kawaoka Y
    Nat Microbiol; 2016 May; 1(6):16058. PubMed ID: 27572841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phylogenetic analyses of influenza A (H1N1)pdm09 hemagglutinin gene during and after the pandemic event in Brazil.
    Resende PC; Motta FC; Born PS; Machado D; Caetano BC; Brown D; Siqueira MM
    Infect Genet Evol; 2015 Dec; 36():147-155. PubMed ID: 26371065
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunogenicity and safety of H1N1 influenza hemagglutinin protein expressed in a baculovirus system.
    Na HN; Kim KH; Song MK; Park HL; Lee EY; Shim SH; Park S; Nam JH
    Microbiol Immunol; 2013 Sep; 57(9):660-4. PubMed ID: 23822120
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cross-Reactive Neuraminidase-Inhibiting Antibodies Elicited by Immunization with Recombinant Neuraminidase Proteins of H5N1 and Pandemic H1N1 Influenza A Viruses.
    Liu WC; Lin CY; Tsou YT; Jan JT; Wu SC
    J Virol; 2015 Jul; 89(14):7224-34. PubMed ID: 25948745
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A virus-like particle vaccination strategy expands its tolerance to H3N2 antigenic drift by enhancing neutralizing antibodies against hemagglutinin stalk.
    Yang JR; Cheng CY; Chen CY; Lin CH; Kuo CY; Huang HY; Wu FT; Yang YC; Wu CY; Liu MT; Hsiao PW
    Antiviral Res; 2017 Apr; 140():62-75. PubMed ID: 28093338
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular evolution of human H1N1 and H3N2 influenza A virus in Thailand, 2006-2009.
    Suwannakarn K; Chieochansin T; Thongmee C; Makkoch J; Praianantathavorn K; Theamboonlers A; Sreevatsan S; Poovorawan Y
    PLoS One; 2010 Mar; 5(3):e9717. PubMed ID: 20300536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hydrophobin fusion of an influenza virus hemagglutinin allows high transient expression in Nicotiana benthamiana, easy purification and immune response with neutralizing activity.
    Jacquet N; Navarre C; Desmecht D; Boutry M
    PLoS One; 2014; 9(12):e115944. PubMed ID: 25541987
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oligomerization of bacterially expressed H1N1 recombinant hemagglutinin contributes to protection against viral challenge.
    Kuenstling TE; Sambol AR; Hinrichs SH; Larson MA
    Sci Rep; 2018 Aug; 8(1):11856. PubMed ID: 30087372
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antigenic and genetic variation in the hemagglutinins of H1N1 and H3N2 human influenza a viruses in the Shanghai area from 2005 to 2008.
    Ren XW; Ju LW; Yang JX; Lv XH; Jiang LF; Zhao NQ; Jiang QW
    J Med Virol; 2011 Jul; 83(7):1113-20. PubMed ID: 21520138
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of broadly neutralizing H1N1 influenza antibodies by vaccination.
    Wei CJ; Boyington JC; McTamney PM; Kong WP; Pearce MB; Xu L; Andersen H; Rao S; Tumpey TM; Yang ZY; Nabel GJ
    Science; 2010 Aug; 329(5995):1060-4. PubMed ID: 20647428
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inactivated H7 Influenza Virus Vaccines Protect Mice despite Inducing Only Low Levels of Neutralizing Antibodies.
    Kamal RP; Blanchfield K; Belser JA; Music N; Tzeng WP; Holiday C; Burroughs A; Sun X; Maines TR; Levine MZ; York IA
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28768855
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Purification and immunogenicity of hemagglutinin from highly pathogenic avian influenza virus H5N1 expressed in Nicotiana benthamiana.
    Pua TL; Chan XY; Loh HS; Omar AR; Yusibov V; Musiychuk K; Hall AC; Coffin MV; Shoji Y; Chichester JA; Bi H; Streatfield SJ
    Hum Vaccin Immunother; 2017 Feb; 13(2):306-313. PubMed ID: 27929750
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mapping of a Novel H3-Specific Broadly Neutralizing Monoclonal Antibody Targeting the Hemagglutinin Globular Head Isolated from an Elite Influenza Virus-Immunized Donor Exhibiting Serological Breadth.
    Qiu Y; Stegalkina S; Zhang J; Boudanova E; Park A; Zhou Y; Prabakaran P; Pougatcheva S; Ustyugova IV; Vogel TU; Mundle ST; Oomen R; Delagrave S; Ross TM; Kleanthous H; Qiu H
    J Virol; 2020 Feb; 94(6):. PubMed ID: 31826999
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extending the Stalk Enhances Immunogenicity of the Influenza Virus Neuraminidase.
    Broecker F; Zheng A; Suntronwong N; Sun W; Bailey MJ; Krammer F; Palese P
    J Virol; 2019 Sep; 93(18):. PubMed ID: 31375573
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Repeat vaccination reduces antibody affinity maturation across different influenza vaccine platforms in humans.
    Khurana S; Hahn M; Coyle EM; King LR; Lin TL; Treanor J; Sant A; Golding H
    Nat Commun; 2019 Jul; 10(1):3338. PubMed ID: 31350391
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of a Pan-H1 Influenza Vaccine.
    Darricarrère N; Pougatcheva S; Duan X; Rudicell RS; Chou TH; DiNapoli J; Ross TM; Alefantis T; Vogel TU; Kleanthous H; Wei CJ; Nabel GJ
    J Virol; 2018 Nov; 92(22):. PubMed ID: 30185594
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An H1-H3 chimeric influenza virosome confers complete protection against lethal challenge with PR8 (H1N1) and X47 (H3N2) viruses in mice.
    Abdoli A; Soleimanjahi H; Tavassoti Kheiri M; Jamali A; Mazaheri V; Abdollahpour Alitappeh M
    Pathog Dis; 2014 Dec; 72(3):197-207. PubMed ID: 25066138
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immune efficacy of an adenoviral vector-based swine influenza vaccine against antigenically distinct H1N1 strains in mice.
    Wu Y; Yang D; Xu B; Liang W; Sui J; Chen Y; Yang H; Chen H; Wei P; Qiao C
    Antiviral Res; 2017 Nov; 147():29-36. PubMed ID: 28941982
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of influenza vaccine immunogenicity using influenza antigen microarrays.
    Price JV; Jarrell JA; Furman D; Kattah NH; Newell E; Dekker CL; Davis MM; Utz PJ
    PLoS One; 2013; 8(5):e64555. PubMed ID: 23734205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.